B
BioRestorative Therapies, Inc. (BRTX)
NCM – Real Time Price. Currency in USD
0.37
-0.02 (-6.19%)
At close: Jun 26, 2026, 4:00 PM EDT
0.38
+0.01 (2.79%)
After-hours: Jun 26, 2026, 7:31 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.37
-0.02 (-6.19%)
At close: Jun 26, 2026, 4:00 PM EDT
0.38
+0.01 (2.79%)
After-hours: Jun 26, 2026, 7:31 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $3.1M significantly exceed its total debt $34.5K, ensuring strong financial flexibility
Total current assets $3.8M exceed Total current liabilities $1.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$3.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.35 | 6.05 | 10 | |
| Quick ratio | 2.35 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 120K | 146K | 401K | 360K | 358K |
| Gross Profit | -744.00 | -20K | 184K | 126K | 119K |
| Operating Income | -19M | -15M | -12M | -16M | -14M |
| Net Income | -13M | -10M | -9M | -14M | -11M |
| EBITDA | -19M | -15M | -11M | -15M | -14M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 10.56 | 58.33 | 8.5 |
| Next quarter | 3035.59 | 69.7 | 10 |
| Current year | 290.28 | 68.67 | 10 |
| Next year | 64.59 | 18.18 | 9.5 |
| Weighted average score | 9.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 18.21 | 32.84 | 39.39 | -52.62 | 7.5 |
| Y/Y | -7.31 | 59.65 | 68.75 | -35.25 | 5.5 |
| 3y average | 62.15 | -7.85 | 20.98 | -21.3 | 5.5 |
| 5y average | 61.32 | -49.27 | 20.98 | -43.76 | 5.5 |
| Weighted average score | 6.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |